HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
Nakaraang pagsara
$6.82
Sakop ng araw
$6.54 - $6.83
Sakop ng taon
$6.38 - $29.60
Market cap
140.61M USD
Average na Volume
202.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 3.78M | -69.64% |
Net na kita | -18.48M | 41.36% |
Net profit margin | — | — |
Kita sa bawat share | -0.89 | 71.29% |
EBITDA | -19.93M | 36.81% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 173.83M | 22.89% |
Kabuuang asset | 253.80M | 5.13% |
Kabuuang sagutin | 85.77M | -22.22% |
Kabuuang equity | 168.03M | — |
Natitirang share | 20.80M | — |
Presyo para makapag-book | 0.84 | — |
Return on assets | -20.02% | — |
Return on capital | -20.94% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -18.48M | 41.36% |
Cash mula sa mga operasyon | -19.84M | 14.65% |
Cash mula sa pag-invest | -2.33M | -103.47% |
Cash mula sa financing | -116.00K | -1,550.00% |
Net change in cash | -22.29M | -150.90% |
Malayang cash flow | -7.13M | 57.79% |
Tungkol
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Itinatag
Ene 1, 2006
Headquarters
Website
Mga Empleyado
121
